MIXiii Biomed 2019 ConferenceMay. 14, 2019
An article by IATI CEO Karin Mayer Rubinstein and IATI Co-Chair (Life Science) Yaacov Michlin opened the special Biomed supplement by Haaretz-TheMarker, published towards our MIXiii-Biomed Conference.
Israel’s life sciences firms said to raise record $1.5 billion in 2018 - The Times Of Israel.
Interview with the CEO of Caribou, a keynote speaker on MIXiii-Biomed 2019 - Globes.
Israel Innovation Authority, Mayo Clinic set up joint healthcare program - The Times Of Israel and JNS.
Israeli companies help bring health innovations to North of England - Digital Health Age.
Israeli startup seeks to boost bone renewal and allow targeted drug delivery - The Times Of Israel.
Philips executive who will give a keynote speech at MIXiii Biomed explains why Israel is tops in biotech - Israeli21c.
During MIXiii-Biomes, Mayo Clinic Announces Partnership with Israel Innovation Authority - Bizzness, Cleveland Jewish News, .
Cannabis-based drug R&D finally going mainstream - BioWorld.
Here’s some advice for medtech startups: Don’t do your homework, CEOs say - FierceBiotech.
To Philips, the future means selling more than a better MRI machine - FierceBiotech.
Israeli Biomed tries to notify sportsmen on heart failure - Globes (Hebrew).
Israeli Digital Health Innovation a 'compelling opportunity' for Investors - The Jerusalem Post.
K Turns To Israel For More Medtech Innovation - Medtech Insight.
Mining data, Israeli healthcare provider flags colon-cancer risk patients - The Times of Israel.
Inside ALYN Innovation, Israel’s One-Stop Shop For Pediatric Rehab Tech - Medtech Insight.
An interview with CEO of VBL, who will be presenting as part of the oncology track at MiXiii Biomed - Scrip.
Interview with CEO of CytoReason which will present at the AI and Digital Health tracks at MIXiii BIOMED - Fierce Pharma.
Ziv Shilon of 6Degrees will share his story as a speaker at the rehabilitation track of the MIXiii-BIOMED 2019 Conference - The Jerusalem Post.
Kitov to Present Clinical Development Plan for Oncology Candidate NT-219 at the 18th MIXiii-BIOMED Conference - GlobeNewswire.
La Innovación En Salud Digital De Israel Es Una “Oportunidad Atractiva” Para Los inversores - Notixias De Israel.